Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Topiramate NDC 16571-708 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Kaplan-Meier Estimates of Cumulative Rates for Time to First Seizure - topiramate fig1

Figure 1: Kaplan-Meier Estimates of Cumulative Rates for Time to First Seizure - topiramate fig1

The text contains a table showing cumulative rates for time to the first seizure for two groups of patients who were administered different doses of Topiramate. The table also indicates time in days on the horizontal axis and increasing doses of Topiramate on the vertical axis. No further information is provided.*

Figure 2 - topiramate fig2

Figure 2 - topiramate fig2

This is a study report that compares the effects of different doses of Topiramate and a placebo on a group of people. The individuals were divided into groups and given different doses of Topiramate ranging from 50mg to 200mg a day, while some were given a placebo. The study measured the change from baseline to double-blind phase in average monthly rates at different periods. The study concludes that the differences between doses of Topiramate and the placebo are statistically significant.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (60 Tablets Bottle) - topiramate fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (60 Tablets Bottle) - topiramate fig3

Topiramate Tablets USP is a medication composed of 25mg of Topiramate USP in each film-coated tablet. It comes in a tight container with 60 Tablets. The distributor of the medicine is Rising Pharma Holdings, Inc. and it is made in India. The product literature should be referred to for dosage and other prescribing information. It's important to store the medicine at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) and protect from moisture. Pharmacist is required to dispense the medication along with the medication guide. The information printed on the dotted line is not to be printed.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (60 Tablets Bottle) - topiramate fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (60 Tablets Bottle) - topiramate fig4

Topiramate USP 50mg tablets are distributed by Rising Pharma Holdings Inc. The usual dosage and other prescribing information can be found on the accompanying medication guide. The tablets should be dispensed in a container that protects them from moisture. The text also contains some printing instructions not to be printed.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (60 Tablets Bottle) - topiramate fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (60 Tablets Bottle) - topiramate fig5

Topiramate is a medication available in the form of 60 film-coated tablets containing 100 mg of Topiramate USP. It is dispensed with a medication guide and should be stored in a tight container, protected from moisture, and at a temperature of 20° to 25°C (68° to 77°F). The dosage information and other details can be found in the product literature that accompanies the medication. It is distributed by Rising Pharma Holdings, Inc. and is manufactured in India. The code for the product is TS/DRUGS/19/1993, issued in March 2021.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg (60 Tablets Bottle) - topiramate fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg (60 Tablets Bottle) - topiramate fig6

Topiramate Tablets USP is a medication that comes in a pack of 60 film-coated tablets, each containing 200 mg of Topiramate. The medicine guide is to be dispensed separately. It is imperative to store the tablets in airtight containers and protect them from moisture. Please see the accompanying product literature for prescribing information and dosage. The product is distributed by Rising Pharma Holdings, Inc. and made in India. The code listed is TS/DRUGS/19/1993, and the issue date is 03/2021. The rest of the text contains printing instructions and codes and is not relevant.*

chemical structure - topiramate str

chemical structure - topiramate str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.